Are cholesterol levels being checked and managed appropriately in UK primary care type 2 diabetes?
Department of Blood Sciences, Walsall Manor Hospital, Walsall, UK. mark.livingston@nhs.net.
M
M
Livingston
Primis, The University of Nottingham, Nottingham, UK.
J C
JC
Robinson
Department of Endocrinology, Leighton Hospital, Crewe, UK.
C E
CE
Brown
Manchester Academic Health Sciences Centre, School of Medicine, University of Manchester, Manchester, UK.
R P
RP
Narayanan
National Pathology Benchmarking Service, Department of Medicines Management, Keele University, Staffordshire, UK.
D
D
Holland
Department of Clinical Biochemistry, Keele University School of Medicine, University Hospital of North Staffordshire, Stoke-on-Trent, UK.
A A
AA
Fryer
Department of Endocrinology, Leighton Hospital, Crewe, UK.|Manchester Academic Health Sciences Centre, School of Medicine, University of Manchester, Manchester, UK.
A H
AH
Heald
D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D019983:Guideline Adherence / Q000592:standards*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D011320:Primary Health Care / Q000592:standards*; D006113:United Kingdom
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol